Historical perspective and emergence of the GABA B receptor

Advances in Pharmacology

Volumn 58, Issue C, 2010, Pages 1-18

  Bowery, N G ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

G protein coupled receptor; Postsynaptic receptor; Presynaptic receptor

Indexed keywords

2 HYDROXYSACLOFEN; 2,6 DI TERT BUTYL 4 (3 HYDROXY 2,2 DIMETHYLPROPYL)PHENOL; 3 AMINOPROPANEPHOSPHONIC ACID; 3 AMINOPROPYL(DIETHOXYMETHYL)PHOSPHINIC ACID; 3 AMINOPROPYLBUTYLPHOSPHINIC ACID; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; 5,5 DIMETHYL 2 MORPHOLINEACETIC ACID; ARBACLOFEN PLACARBIL; BACLOFEN; BENZYL[3 [[1 (3,4 DICHLOROPHENYL)ETHYL]AMINO] 2 HYDROXYPROPYL]PHOSPHINIC ACID; BETA ADRENERGIC RECEPTOR; LESOGABERAN; N,N' DICYCLOPENTYL 2 METHYLTHIO 5 NITRO 4,6 PYRIMIDINEDIAMINE; PHACLOPHEN; SACLOFEN; TIAGABINE; UNCLASSIFIED DRUG; LIGAND;

ABSENCE; ANXIETY DISORDER; ARTICLE; CENTRAL NERVOUS SYSTEM; COCAINE DEPENDENCE; COGNITION; COGNITIVE DEFECT; DEPRESSION; DIZZINESS; DROWSINESS; DRUG DEPENDENCE; DRUG EFFECT; DRUG MEGADOSE; DRUG PENETRATION; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG TOLERABILITY; GASTROESOPHAGEAL REFLUX; HALLUCINATION; HUMAN; HYPOTENSION; INTERNEURON; MEMORY; MENTAL DISEASE; MUSCLE RELAXATION; MUSCLE WEAKNESS; NAUSEA; NERVE CELL; NEUROMODULATION; NONHUMAN; PANCREAS CANCER; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN FUNCTION; SEIZURE; SKELETAL MUSCLE; SPASTICITY; STRUCTURE ACTIVITY RELATION; SYNAPTIC TRANSMISSION; TISSUE DISTRIBUTION; TRANQUILIZING ACTIVITY; ALLOSTERISM; ANIMAL; HISTORY; METABOLISM; PROTEIN TRANSPORT;

ALLOSTERIC REGULATION; ANIMALS; HISTORY, 20TH CENTURY; HUMANS; LIGANDS; PROTEIN TRANSPORT; RECEPTORS, GABA-B;

EID: 77955026661     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1054-3589(08)57001-3     Document Type: Chapter

References (110)

1. Adams P.R., Brown D.A. Actions of γ-aminobutyric acid on sympathetic ganglion cells. Journal of Physiology (London) 1975, 250:85-120.
2. B -mediated response. Methods and Findings in Experimental and Clinical Pharmacology 1991, 13:681-686.
3. B ) receptor agonists as gastroesophageal reflux inhibitors. Journal of Medicinal Chemistry 2008, 51:4315-4320.
4. Ashby C.R., Rohatgi R., Ngosuwan J., et al. Implication of the GABA(B) receptor in gamma vinyl-GABA's inhibition of cocaine-induced increases in nucleus accumbens dopamine. Synapse 1999, 31:151-153.
5. 2+ channels. Neuroscience Letters 2000, 283:33-36.
6. Bowery N.G., Brown D.A. Depolarising actions of γ-aminobutyric acid and related compounds on rat superior cervical ganglia in vitro. British Journal of Pharmacology 1974, 50:205-218.
7. Bowery N.G., Bettler B., Froestl W., et al. Mammalian gamma-aminobutyric acid (B) receptors: structure and function. Pharmac Revs 2000, 54(2):247-264.
8. Bowery N.G., Doble A., Hill D.R., et al. Bicuculline-insensitive GABA receptors on peripheral autonomic nerve terminals. European Journal of Pharmacology 1981, 71:53-70.
9. B receptor binding sites on rat whole brain synaptic membranes. British Journal of Pharmacology 1983, 78:191-206.
10. Bowery N.G., Hill D.R., Hudson A.L., et al. (-)Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor. Nature 1980, 283:92-94.
11. B receptor site distribution in rat central nervous system. Neuroscience 1987, 20:365-385.
12. Bredenoord A.J. Lesogaberan, a GABA(B), agonist for the potential treatment of gastroesophageal reflux disease. IDrugs 2009, 12:576-584.
13. Brusberg M., Ravnefjord A., Martinsson R., et al. The GABA(B) receptor agonist, baclofen, and the positive allosteric modulator, CGP7930, inhibit visceral pain-related responses to colorectal distension in rats. Neuropharmacology 2009, 56:362-367.
14. Calver A.R., Medhurst A.D., Robbins M.J., et al. The expression of GABA(B1) and GABA(B2) receptor subunits in the CNS differs from that in peripheral tissues. Neuroscience 2000, 100:155-170.
15. B receptors in the lung. Trends in Pharmacological Sciences 1993, 14:26-29.
16. B2 subunits in rat brain, spinal cord, and dorsal root ganglion. Neuroscience 2001, 106:447-467.
17. B autoreceptor modulation of P/Q-type calcium channels and GABA release in rat suprachiasmatic nucleus neurons. Journal of Neuroscience 1998, 18:1913-1922.
18. B binding sites in rat central nervous system: A quantitative autoradiographic study. Neuroscience 1990, 34:341-357.
19. Colmers W.F., Pittman Q.J. Presynaptic inhibition by neuropeptide Y and baclofen in hippocampus: Insensitivity to pertussis toxin treatment. Brain Research 1989, 498:99-104.
20. Corrigall W.A., Coen K.M., Adamson K.L., et al. Response of nicotine self-administration in the rat to manipulations of mu-opioid and gamma-aminobutyric acid receptors in the ventral tegmental area. Psychopharmacology 2000, 149:107-114.
21. B receptors in anxiety and depression. Trends in Pharmacological Sciences 2005, 26:36-43.
22. B receptor activation. The GABA receptors 1997, 237-258. Humana Press, Totowa, NJ. S.J. Enna, N.G. Bowery (Eds.).
23. Curtis D.R. Gamma-aminobutyric and glutamic acids as mammalian central transmitters. Metabolic compartmentation and neurotransmission 1975, 11-36. Plenum Press, New York. S. Berl, D.D. Clarke, D. Schneider (Eds.).
24. Curtis D.R. Pre- and non-synaptic activities of GABA and related amino acids in the mammalian nervous system. sAmino acids as chemical transmitters 1977, 55-86. Plenum Press, New York. F. Fonnum (Ed.).
25. Davies C.H., Davies S.N., Collingridge G.L. Paired-pulse depression of monosynaptic GABA-mediated inhibitory postsynaptic responses in rat hippocampus. Journal of Physiology 1990, 424:513-531.
26. B receptors. The GABA receptors 1997, 157-207. Humana Press, Totowa, NJ. S.J. Enna, N.G. Bowery (Eds.).
27. B receptors on A and C primary afferents. British Journal of Pharmacology 1984, 81:327-333.
28. B receptors in the basal forebrain selectivity impairs working memory of rats in the double Y-maze. Brain Research 1994, 641:29-38.
29. B receptor-mediated inhibition of GABA release in area CA1 of the rat hippocampus. Journal of Neurophysiology 1995, 74:43-53.
30. Dunlap K. Two types of γ-aminobutyric acid receptor on embryonic sensory neurons. British Journal of Pharmacology 1981, 74:59-585.
31. Durkin M.M., Gunwaldsen C.A., Borowsky B., et al. An in situ hybridization study of the distribution of the GABA(B2) protein mRNA in the rat CNS. Molecular Brain Research 1999, 71:185-200.
32. B receptors in the central nervous system. Nature 1988, 332:156-158.
33. B receptors in the hippocampus have different pharmacological properties. Neuron 1988, 1:585-591.
34. B receptor alterations as indicators of physiological and pharmacological function. Biochemical Pharmacology 2004, 68:1541-1548.
35. Enna S.J., Snyder S. Properties of γ-aminobutyric acid (GABA) receptor binding in rat brain synaptic membrane fractions. Brain Research 1975, 100:81-97.
36. Enna S.J., Snyder S. Influences of ions, enzymes, and detergents on γ-aminobutyric acid receptor binding in synaptic membranes of rat brain. Molecular Pharmacology 1977, 13:442-453.
37. GABAergic mechanisms in the mammalian periphery 1986, Raven, New York. S.L. Erdo, N.G. Bowery (Eds.).
38. B receptor antagonist in clinical trials. Biochemical Pharmacology 2004, 68:1479-1487.
39. + channels by GABA. Trends in Neurosciences 1992, 15:46-51.
40. Genkova-Papazova M.G., Petkova B., Shishkova N., et al. The GABA-B antagonist CGP 36742 prevent PTZ-kindling-provoked amnesia in rats. European Neuropsychopharmacology 2000, 10:273-278.
41. B receptors in mammalian function 1990, 208-221. Wiley, Chichester. N.G. Bowery, H. Bittiger, H.-R. Olpe (Eds.).
42. B receptor modulation of adenylate cyclase activity in rat brain slices. British Journal of Pharmacology 1985, 84:249-257.
43. 3 H-GABA bind to bicuculline-insensitive GABAB sites in rat brain. Nature 1981, 290:149-152.
44. B receptor activation: Parallel antinociceptive testing and medial thalamus GABA microdialysis. European Journal of Pharmacology 1999, 368:205-211.
45. B receptor-mediated modulation of presynaptic currents and excitatory transmission at a fast central synapse. Journal of Neurophysiology 1998, 80:1571-1576.
46. Isaacson J.S., Solis J.M., Nicoll R.A. Local and diffuse synaptic actions of GABA in the hippocampus. Neuron 1993, 10:165-175.
47. John J.P., Sunyer B., Höger H., et al. Hippocampal synapsin isoform levels are linked to spatial memory enhancement by SGS742. Hippocampus 2009, 19:731-738.
48. B R2. Nature 1998, 396:674-679.
49. Karbon E.W., Enna S.J. Characterization of the relationship between gamma-aminobutyric acid B agonists and transmitter-coupled cyclic nucleotide-generating systems in rat brain. Molecular Pharmacology 1985, 27(1):53-59.
50. B receptors and norepinephrine-stimulated cAMP production in rat brain cortex. Brain Research 1984, 306:327-332.
51. B -receptor subtypes assemble into functional heteromeric complexes. Nature 1998, 396:683-687.
52. B receptors. Pharmacology & Therapeutics 1995, 67:187-246.
53. Kerr D.I.B., Ong J., Prager R.H., et al. Phaclofen: A peripheral and central baclofen antagonist. Brain Research 1987, 405:150-154.
54. Kleinrok A., Kilbinger H. γ-Aminobutyric acid and cholinergic transmission in the guinea-pig ileum. Naunyn-Schmiedeberg's Archives of Pharmacology 1983, 322:216-220.
55. B in rat brain slices. Neuropharmacology 1996, 35:703-712.
56. Krnjevic K. Chemical nature of synaptic transmission in vertebrates. Physiological Reviews 1974, 54:418-540.
57. Krnjevic K., Schwartz S. The action of γ-aminobutyric acid on cortical neurons. Experimental Brain Research 1967, 3:320-336.
58. B receptor function. Science 1999, 283:74-77.
59. Lal R., Sukbuntherng J., Tai E.H., et al. Arbaclofen placarbil, a novel R-baclofen prodrug: Improved absorption, distribution, metabolism, and elimination properties compared with R-baclofen. Journal of Pharmacology and Experimental Therapeutics 2009, 330:911-921.
60. B receptors. Journal of Physiology 1996, 492:115-127.
61. Lasarge C.L., Bañuelos C., Mayse J.D., et al. Blockade of GABA(B) receptors completely reverses age-related learning impairment. Neuroscience 2009, 164:941-947.
62. B receptor inhibits transient lower esophageal sphincter relaxations in dogs. Gastroenterology 1999, 117:1147-1154.
63. A receptor heterogeneity. Nature 1988, 335:76-77.
64. Liebman J.M., Pastor G. Antinociceptive effects of baclofen and muscimol upon intraventricular administration. European Journal of Pharmacology 1980, 61:225-230.
65. Ling W., Shoptaw S., Majewska D. Baclofen as an anti-craving medication: A preliminary clinical study. Neuropsychopharmacology 1998, 18:403-404.
66. B ) binding sites in rat frontal cortex: A common action of repeated administration of different classes of antidepressant and electroshock. Journal of Pharmacology and Experimental Therapeutics 1985, 235:191-199.
67. + channels (GIRKs) mediate postsynaptic but not presynaptic transmitter actions in hippocampal neurons. Neuron 1997, 19:687-695.
68. Maccioni P., Carai M.A., Kaupmann K., et al. Reduction of alcohol's reinforcing and motivational properties by the positive allosteric modulator of the GABAB receptor, BHF177, in alcohol-preferring rats. Alcoholism, Clinical and Experimental Research 2009, 33:1749-1756.
69. Malcangio M., Bowery N.G. GABA and its receptors in the spinal cord. Trends in Pharmacological Sciences 1996, 17:457-462.
70. Manning J.-P., Richards D.A., Bowery N.G. Pharmacology of absence epilepsy. Trends in Pharmacological Sciences 2003, 24:542-549.
71. Margeta-Mitrovic M., Mitrovic I., Riley R.C., et al. Immunohistochemical localization of GABA(B) receptors in the rat central nervous system. Journal of Comparative Neurology 1999, 405:299-321.
72. Meeren H., van Luitelaar G., Lopes da Silva F., et al. Evolving concepts on the pathophysiology of absence seizures. Archives of Neurology 2005, 62:371-376.
73. Mombereau C., Kaupmann K., Froestl W., et al. Genetic and pharmacological of a role for GABAB receptors in the modulation of anxiety- and antidepressant-like behavior. Neuropsychopharmacology 2004, 29:1050-1062.
74. B receptors. International Review of Neurobiology 1994, 36:97-223.
75. B receptor antagonist CGP36742 improves learned helplessness in rats. European Journal of Pharmacology 1999, 381:1-7.
76. Newberry N.R., Nicoll R.A. A bicuculline-resistant inhibitory post-synaptic potential in rat hippocampal pyramidal cells in vitro. Journal of Physiology 1984, 360:161-185.
77. B receptors. Biochemical Pharmacology 2004, 68:1667-1674.
78. Ochs G., Struppler A., Meyerson B.A., et al. Intrathecal baclofen for long term treatment of spasticity: A multicentre study. Journal of Neurology, Neurosurgery, and Psychiatry 1989, 52:933-939.
79. Odagaki Y., Koyama T. Identification of G alpha subtype(s) involved in gamma-aminobutyric acid(B) receptor-mediated high-affinity guanosine triphosphatase activity in rat cerebral cortical membranes. Neuroscience Letters 2001, 297:137-141.
80. Odagaki Y., Nishi N., Koyama T. Functional coupling of GABA(B) receptors with G proteins that are sensitive to N-ethylmaleimide treatment, suramin and benzalkonium chloride in rat cerebral cortical membranes. Journal of Neural Transmission 2000, 107:1101-1116.
81. B receptor antagonists on long term potentiation. Naunyn-Schmiedeberg's Archives of Pharmacology 1990, 342:194-197.
82. B - receptor-mediated modification of intestinal motility. European Journal of Pharmacology 1983, 86:9-17.
83. Ong J., Kerr D.I.B. GABA receptors in peripheral tissues. Life Sciences 1990, 46:489-1501.
84. Orsnes G.B., Sorensen P.S., Larsen T.K., et al. Effect of baclofen on gait in spastic MS patients. Acta Neurologica Scandinavica 2000, 101:244-248.
85. Penn R.D., Savoy S.M., Corcos D., et al. Intrathecal baclofen for severe spinal spasticity. New England Journal of Medicine 1989, 320:1517-1521.
86. B agonists and serotonin in cultured hippocampal neurons. Journal of Neurophysiology 1994, 71:2570-2575.
87. Price G.W., Kelly J.S., Bowery N.G. The location of GABAB receptor binding sites in mammalian spinal cord. Synapse 1987, 1:530-538.
88. B receptors present on primary afferent terminals of the spinal cord?. Nature 1984, 307:71-74.
89. Riley R.C., Trafton J.A., Chi S.I., et al. Presynaptic regulation of spinal cord tachykinin signaling via GABA(B) but not GABA(A) receptor activation. Neuroscience 2001, 103:725-737.
90. Roberts D.C.S., Andrews M.M. Baclofen suppression of cocaine self-administration: Demonstration using a discrete trials procedure. Psychopharmacology 1997, 131:271-277.
91. B receptors in rat cerebrocortical synaptosomes. Neurochemistry International 1995, 27:397-406.
92. B1 . Neuron 2001, 31:47-58.
93. B receptor is a novel drug target for pancreatic cancer. Cancer 2008, 112:767-778.
94. A receptor shows a ligand-gated receptor superfamily. Nature 1987, 328:221-227.
95. B receptor on cocaine self-administration in rats. Psychopharmacology 2004, 173:105-111.
96. Stackman R.J., Walsh T.J. Baclofen produces dose related working memory impairments after intraseptal injection. Behavioral and Neural Biology 1994, 61:181-185.
97. Sunyer B., Diao W.F., Kang S.U. Cognitive enhancement by SGS742 in OF1 mice is linked to specific hippocampal protein expression. Journal of Proteome Research 2008, 7:5237-5253.
98. B receptors in tissues from pharmacoresistant epilepsy patients. Epilepsia 2009, doi: 10.1111/j.1528-1167.2009.
99. A receptors. The GABA receptors 1997, 83-120. Humana Press, Totowa, NJ. S.J. Enna, N.G. Bowery (Eds.).
100. B receptors. Allosteric receptor modulation in drug targeting 2006, 235-257. Taylor & Francis, New York. N.G. Bowery (Ed.).
101. B receptors by 2,6-di-tert-butyl-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol(CGP7930) and its aldehyde analog CGP13501. Molecular Pharmacology 2001, 60:963-971.
102. B . Journal of Pharmacology and Experimental Therapeutics 2003, 307:322-330.
103. B receptors are couple to a barium-insensitive outward rectifying potassium conductance in premotor respiratory neurons. Journal of Neurophysiology 1993, 69:286-289.
104. B receptor. Nature 1998, 396:679-682.
105. B receptors in rat cerebellum. Nature 1981, 294:584-597.
106. Wilson P.R., Yaksh T.L. Baclofen is anti-nociceptive in the intrathecal space of animals. European Journal of Pharmacology 1978, 51:323-330.
107. 2+ influx. Journal of Physiology 1995, 485:649-657.
108. Xi Z.X., Stein E.A. Baclofen inhibits heroin self-administration behavior and mesolimbic dopamine release. Journal of Pharmacology and Experimental Therapeutics 1999, 290:1369-1374.
109. Xu J., Wojcik W.J. Gamma aminobutyric acid B receptor-mediated inhibition of adenylate cyclase in cultured cerebellar granule cells: Blockade by islet-activating protein. Journal of Pharmacology and Experimental Therapeutics 1986, 239:568-573.
110. Zukin S., Young A., Snyder S., et al. Gamma-aminobutyric acid binding to receptor sites in the rat central nervous system. Proceedings of the National Academy of Sciences of the United States of America 1974, 71:4802-4807.